Niperotidine
WikiDoc Resources for Niperotidine |
Articles |
---|
Most recent articles on Niperotidine Most cited articles on Niperotidine |
Media |
Powerpoint slides on Niperotidine |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Niperotidine at Clinical Trials.gov Clinical Trials on Niperotidine at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Niperotidine
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Niperotidine Discussion groups on Niperotidine Patient Handouts on Niperotidine Directions to Hospitals Treating Niperotidine Risk calculators and risk factors for Niperotidine
|
Healthcare Provider Resources |
Causes & Risk Factors for Niperotidine |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Niperotidine is a histamine antagonist selective for the H2 subtype. It was trialled as a treatment for excessive gastric acidity,[1] but withdrawn after human trials showed liver damage.[2]
References
- ↑ Palasciano G, Maggi V, Portincasa P. The effect of the H2-antagonist niperotidine on intragastric acidity in healthy subjects undergoing 24-hour pH-monitoring. Italian Journal of Gastroenterology. 1990 Oct;22(5):291-4. PMID 1983712
- ↑ Gasbarrini G, Gentiloni N, Febbraro S, Gasbarrini A, Di Campli C, Cesana M, Miglio F, Miglioli M, Ghinelli F, D'Ambrosi A, Amoroso P, Pacini F, Salvadori G. Acute liver injury related to the use of niperotidine. Journal of Hepatology. 1997 Sep;27(3):583-6. PMID 9314138